Physicians' Academy for Cardiovascular Education

Agenda Topics ▼Video ▼Online-CME News ▼Meeting Reports Slides ▼About

ACC 2020 ▼AHA 2019 ▼Covid-19 ▼Diabetes & CVD ▼EAS 2019 ▼ESC 2019 ▼ESC Diabetes guidelines 2019 ▼ESC/EAS Guidelines dyslipidaemias 2019 ▼HFpEF: The essentials to know ▼LDL-c Key Lessons ▼

HoFH

Feb. 8, 2014

Share this page with your colleagues and friends:

Continue reading:

4 Things a cardiologist should know about triglycerides

Reducing triglycerides in REDUCE-IT

10' education - Feb. 11, 2020 - Prof. Deepak Bhatt, MD - Online CME

The spectrum of triglyceride-containing lipoproteins

10' education - Feb. 4, 2020 - Jorge Plutzky, MD - Online CME

How can triglycerides increase CV risk?

10' education - Jan. 16, 2020 - Prof. Børge Nordestgaard, MD

5 Things a cardiologist should know about diabetes

Slide Curriculum: Diabetes and cardiology

Slides (curriculum) - July 24, 2018

PACE Special: 5 Things a cardiologist should know about diabetes

Download - Download your free copy

Hypoglycemia in cardiovascular medicine: why worry?

10' education - Mar. 7, 2018 - Prof Guntram Schernthaner - Vienna, Austria - Online CME

ACS

Genotype-guided post-PCI antiplatelet therapy just missed significance in reducing ischemic events

News - Mar. 29, 2020

No association between HDL particle concentration and MACE after ACS

Literature - Feb. 10, 2020 - Am Heart J 2019

ACS patients show less dense, calcified plaque than ACS-free controls on clinically indicated CCTA

Literature - Jan. 29, 2020 - Van Rosendael AR et al., - JAMA Cardiol. 2020

Atherosclerosis

Lp(a) and immune metabolism

5' education - Mar. 12, 2020 - EAS-endorsed Lp(a) satellite meeting - Jeffrey Kroon, PhD

EAS consensus statement on key biological mechanisms of LDL-c leading to ASCVD

News - Feb. 27, 2020

Translating ESC/EAS Dyslipidemia Guidelines to clinical practice

10' education - Feb. 18, 2020 - Prof. Kausik Ray, MD

Atrial fibrillation

Oral anticoagulant monotherapy reduces bleeding in AF patients after TAVI

3' education - Mar. 30, 2020 - Dr. Jur ten Berg, MD, PhD - ACC 2020

OAC alone reduces bleeding in AF patients after TAVI

News - Mar. 30, 2020

Integrated care for elderly AF patients can be safely organized in primary care

Literature - Mar. 9, 2020 - Van den Dries CJ, Van Doorn S, Rutten FH et al., - Eur Heart J. 2020.

BET Inhibition

Effect of BET inhibition on CV outcomes in ACS and diabetes patients

10' education - Dec. 9, 2019 - Prof. Kausik Ray, MD

Primary endpoint not met for BET inhibitor in phase 3 trial

News - Sep. 30, 2019

BET inhibition, an epigenetic pathway: How could BET inhibition modulate atherothrombotic risk?

10' education - Sep. 30, 2019 - Prof. Wouter Jukema

Covid-19

The CAPACITY COVID registry: a call to collect CV data of COVID-19 patients

News - Mar. 31, 2020

CAPACITY COVID: a registry of CV variables in patients with COVID-19

3' education - Mar. 31, 2020 - Prof. Folkert Asselbergs, MD, PhD

Issues in the cath lab during COVID-19 outbreak

Literature - Mar. 24, 2020 - Welt FGP, et al. - JACC 2020

CV Inflammation

Higher olive oil consumption associated with lower CV and CHD risk in U.S. adults

Literature - Mar. 24, 2020 - Guasch-Ferré M et al., - J Am Coll Cardiol. 2020.

Coronavirus infections and the cardiovascular system

Literature - Mar. 19, 2020 - Xiong TY, et al. - Eur Heart J. 2020

Lp(a) and immune metabolism

5' education - Mar. 12, 2020 - EAS-endorsed Lp(a) satellite meeting - Jeffrey Kroon, PhD

CVRM

The growing global challenge of CV risk

5' education - Jan. 15, 2020 - Thomas Gaziano, MD

Persons with NAFLD are not automatically at high risk of acute MI or stroke

Literature - Nov. 4, 2019 - Alexander M et al, - BMJ 2019

Not only weight loss, but also maintaining a lower weight is important for a good CV risk profile

Literature - Oct. 14, 2019 - Berger SE et al., - J Am Heart Assoc. 2019

Diabetes

Consistent findings with NOAC plus aspirin in CAD and PAD with and without diabetes

3' education - Mar. 29, 2020 - Prof. Deepak Bhatt, MD - ACC 2020

NOAC plus aspirin reduces CV events in stable CAD and/or PAD patients with and without diabetes

News - Mar. 29, 2020

Irregular sleep duration and timing associated with increased risk of CVD

Literature - Mar. 24, 2020 - Huang T et al., - J Am Coll Cardiol. 2020.

Epigenetics in CVD

Effect of BET inhibition on CV outcomes in ACS and diabetes patients

10' education - Dec. 9, 2019 - Prof. Kausik Ray, MD

BET inhibitor therapy did not meet primary endpoint of reducing MACE in post-ACS patients with T2DM

News - Nov. 17, 2019

Clinical update on BET inhibition: The patient profile that may benefit from BET inhibition

10' education - Aug. 31, 2019 - Prof. Kausik Ray, MD

ESC Diabetes guidelines 2019

Slides: 2019 ESC guidelines on diabetes, pre-diabetes and cardiovascular diseases - Expert insights and rationale

Slides (presentation) - Oct. 7, 2019 - Prof Francesco Cosentino, MD, Stockholm, Sweden - CME symposium held during ESC 2019

The 2019 ESC/EASD diabetes guidelines: a major paradigm shift in the management of T2DM

10' education - Sep. 30, 2019 - Paris, France - Prof. Francesco Cosentino, MD

New ESC/EASD Guidelines on diabetes no longer regard metformin as first-line therapy

News - Sep. 3, 2019

ESC/EAS Guidelines dyslipidaemias 2019

LDL-c targets in the ESC/EAS dyslipidaemia guidelines in a nutshell

10' education - Oct. 4, 2019 - Prof. Brian Ference, MD

Slides: LDL-c targets in the ESC/EAS dyslipidaemia guidelines in a nutshell

Slides (presentation) - Sep. 9, 2019 - ESC Paris, France - Prof. Brian A. Ference, M.D, University of Cambridge, United Kingdom - CME symposium held during ESC 2019

Rationale for the lower LDL-c targets in the 2019 ESC/EAS Dyslipidemia Guidelines

5' education - Sep. 9, 2019 - Paris, France - Prof. François Mach

Expert Meeting GLP-1, CVD & T2DM

Translation of novel approaches in CVD & diabetes to clinical practice

10' education - Mar. 22, 2018 - John Deanfield, Francesco Cosentino, Filip Knop - Online CME

Novel diabetes drugs in clinical management: Extending the opportunities

10' education - June 5, 2018 - Stefano Taddei, Cees Tack, Massimo Volpe - Online CME

Clinical trials in diabetes and CVD: What did we learn?

10' education - Mar. 22, 2018 - Filippo Crea, Angelyn Bethel, Eduard Montanya - Online CME

Familial Hypercholesterolemia

Remarkable reduction of LCL-c with antibody against angiopoietin-like protein 3 in HoFH

3' education - Apr. 1, 2020 - Prof. Frederick Raal, PhD - ACC 2020

PCSK9 inhibitor reduces LDL-c in patients with HoFH

News - Apr. 1, 2020

Angiopoietin-like protein 3 inhibitor reduces LDL-c in homozygous FH

News - Mar. 31, 2020

GLP-1 RA & CVD

Cardiorenal cross-talk in diabetes: The preventive challenge in DKD for GLP-1 ra

Agenda - June 8, 2020 - ERA EDTA Milan, Italy

GLP-1RA treatment effect in patients with T2DM and PAD

5' education - Jan. 8, 2020 - Prof. Subodh Verma, MD, PhD

Impacting progression and outcomes of DKD: Translating novel insights with GLP-1RA to practice

Online-CME - This course consists of 3 lectures.

Heart Failure

Added value of sGC stimulator in worsening HFrEF patients

3' education - Mar. 31, 2020 - Prof. Paul Armstrong, MD - ACC 2020

sGC stimulator reduces CV death and HF hospitalization in HFrEF patients with worsening HF

News - Mar. 28, 2020

LVEF during hospitalization for acute HF is an independent predictor of clinical outcomes

Literature - Mar. 19, 2020 - Janwanishstaporn S et al., - Eur J Heart Fail. 2020.

$Relationship between left ventricular ejection fraction and cardiovascular outcomes following hospitalization for heart failure: insights from the RELAX-AHF-2 trial$

HFpEF: The essentials to know

HFpEF: Current and future clinical approaches to manage HFpEF

10' education - Aug. 27, 2018 - Burkert Pieske, MD - Berlin, Germany - Online CME

Slides: HFpEF: What are the most likely pathophysiological mechanisms involved in the disease

Slides (presentation) - Aug. 27, 2018 - Carolyn Lam, MD - Singapore

HFpEF: How to diagnose

10' education - Aug. 27, 2018 - Barry Borlaug - Rochester, MN, USA - Online CME

Hypertension

Renal denervation reduces BP in hypertensive patients in absence of medications

News - Apr. 2, 2020

HFSA/ACC/AHA release statement on continued use RAASi during COVID-19 outbreak

News - Mar. 18, 2020

ESC Position statement on continued ACEi and ARBs use in relation to coronavirus COVID-19 outbreak

News - Mar. 16, 2020

Inflammation Expert Opinions

Ultime notizie sulla terapia: Un farmaco anti-infiammatorio riduce eventi cardiovascolari maggiori

5' education - Aug. 27, 2017 - ESC 2017, Barcelona, Spain

Breakthrough therapy: Anti-inflammatory drug can affect important CV outcomes

5' education - Aug. 27, 2017 - ESC 2017, Barcelona, Spain

Clinical implications of inhibiting inflammation as risk factor for progression of CVD

5' education - Aug. 27, 2017

Invest in your arteries

Estimating CV risk and treatment benefit

10' education - June 12, 2018 - Prof. Frank Visseren - Utrecht, The Netherlands - Online CME

Importance of hypertension in CVD prevention

10' education - June 12, 2018 - Prof. Richard Hobbs - Oxford, UK - Online CME

The role of lipids in CVD prevention: Lessons learned about statins

10' education - June 6, 2018 - Prof. Kees Hovingh - Amsterdam, The Netherlands - Online CME

Lipids

Sugar-sweetened beverage consumption associated with adverse changes in HDL-c and triglycerides

Literature - Mar. 5, 2020 - Haslam DE et al., - J Am Heart Assoc. 2020.

PCSK9 inhibitor reduces atherogenic lipids in T2DM patients with mixed dyslipidemia

Literature - Feb. 27, 2020 - Colhoun HM, et al. - Cardiovasc Diabetol 2020

Addressing lipid risk: a system-wide approach to implementation

5' education - Feb. 27, 2020 - Jorge Plutzky, MD

Lp(a)

Genetically elevated Lp(a) levels associated with shorter parental life span

Literature - Mar. 17, 2020 - Arsenault BJ et al., - JAMA Netw Open. 2020

High level of ApoCIII-Lp(a) complexes together with high Lp(a) or OxPL predicts rapid progression of aortic stenosis

Literature - Feb. 26, 2020 - Capoulade R et al. - Heart 2020

Assessing residual lipid risk with advanced testing

5' education - Feb. 17, 2020 - Samia Mora, MD

PCSK9

PCSK9 inhibitor reduces LDL-c in patients with HoFH

News - Apr. 1, 2020

How to implement the newest heart failure therapies? A case based approach

Agenda - May 25, 2020 - ESC Heart Failure, Barcelona, Spain

PCSK9 inhibitor reduces atherogenic lipids in T2DM patients with mixed dyslipidemia

Literature - Feb. 27, 2020 - Colhoun HM, et al. - Cardiovasc Diabetol 2020

Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension: Key questions addressed

Online-CME - This course consists of 3 separate lectures

Why cardiologists should be more interested in PAH

3' education - Mar. 9, 2018 - VBWG at ACC, Orlando, FL, USA - Prof. Mardi Gomberg-Maitland, Falls Church, VA, USA - Online CME

Novel insights in the management and prognosis of pulmonary hypertension

5' education - Aug. 29, 2017 - ESC 2017, Barcelona, Spain - Prof Nazzareno Galiè - Bologna, Italy

Stroke

Higher olive oil consumption associated with lower CV and CHD risk in U.S. adults

Literature - Mar. 24, 2020 - Guasch-Ferré M et al., - J Am Coll Cardiol. 2020.

Challenges in prescribing DOACs for stroke prevention in AF

5' education - Mar. 2, 2020 - Prof. Freek Verheugt and John Eikelboom

P2Y12 inhibitor plus aspirin reduces risk of primary endpoint after acute ischemic stroke or TIA

News - Jan. 28, 2020

© 2006 - 2020 pace-cme.org - About